Design, synthesis, biological and computational evaluation of Thieno[3,2-d]pyrimidine-based inhibitors of JAK3 kinase
- 12 September 2026
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 143, 118806
Abstract
No abstract availableKeywords
Funding Information
- King Mongkut's Institute of Technology Ladkrabang
- National Research Council of Thailand (N42A650386)
This publication has 27 references indexed in Scilit:
- Design and SAR Analysis of Covalent Inhibitors Driven by Hybrid QM/MM Simulations2020
- Tofacitinib, an oral Janus kinase inhibitor, in patients from Colombia with rheumatoid arthritis: Pooled efficacy and safety analyses of data from phase III studiesRevista Colombiana de Reumatología (English Edition), 2018
- Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in HumansJournal of Medicinal Chemistry, 2017
- Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective InhibitionACS Chemical Biology, 2016
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- Development of Selective Covalent Janus Kinase 3 InhibitorsJournal of Medicinal Chemistry, 2015
- Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia VeraCancer Cell, 2008
- Automatic atom type and bond type perception in molecular mechanical calculationsJournal of Molecular Graphics and Modelling, 2006
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004